Plasma concentrations during naltrexone implant treatment of opiate-dependent patients
Linda Olsen1, Asbjørg S Christophersen, Grete Frogopsahl
1Norwegian Institute of Public Health, Division of Forensic Toxicology and Drug Abuse, PO Box 4404 Nydalen, 0403 Oslo, Norway.
Aims:
To evaluate individual variations in plasma concentrations over time in patients with naltrexone implants.
Methods:
Ten opioid-dependent patients received up to four implants. Plasma samples were collected regularly for the analyses of naltrexone and the metabolite beta-naltrexol.
Results:
The median naltrexone C(max) was 12.3 (range 5.8-22.1) ng ml(-1), the median T(max) was 1 day (range 3 h to 35 days), and the median length of time that plasma concentrations were above 1 ng ml(-1) was 55 (range 30-80) days. Two patients reported heroin use without experiencing any effect. Tissue reactions were recorded in two patients after repeated implantation.
Conclusion:
Marked individual and intraindividual variations in naltrexone concentrations were observed. Further studies should be performed to evaluate the need for therapeutic drug monitoring during naltrexone implant treatment.
Related Concept Videos
Drug Concentrations: Measurements
Plasma —...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Drug Distribution: Plasma Protein Binding
Dosage Regimen: Multiple Oral Dosage


